A recent report in The New England Journal of Medicine by Liao and colleagues highlights the benefit of aspirin use in a molecular defined subgroup of patients affected by metastatic colorectal cancer (CRC). Authors concluded that it is very likely…
Fecha:
2013-06-09
Recurso:
Annals of Translational Medicine
CIC - Centro de Información y Conocimiento Johannes Gutenberg ®